AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22535754 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with virgin olive oil (MD-VOO)
Number of subjects: 516
Study 22535754 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with mixed nuts (MD-Nuts)
Number of subjects: 516
Study 22535754 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (LFD)
Number of subjects: 516
Study 22535754 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) groups
Number of subjects: 516
Study 22535754 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest tertile of virgin olive oil and vegetable consumption
Number of subjects: 516
Study 22535754 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in consumption of virgin olive oil and vegetables
Number of subjects: 516
Study 20493957 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (100mg, twice daily)
Number of subjects: 379
Study 20493957 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 379
Study 20493957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 379
Study 16784344 — intervention group
Group type: EXPERIMENTAL
Intervention: Identity expression via in-group bias on symbolic measures in stable, high-status groups
Number of subjects: 0
Study 16784344 — intervention group
Group type: EXPERIMENTAL
Intervention: Material in-group bias for instrumental motives in unstable, low-status groups when communicating with in-group members
Number of subjects: 0
Study 16784344 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme forms of in-group bias for instrumental reasons in stable, low-status groups
Number of subjects: 0
Study 14745756 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-distention
Number of subjects: 50
Study 14745756 — intervention group
Group type: COMPARATOR
Intervention: Water-distention
Number of subjects: 50
Study 11756577 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin
Number of subjects: 16
Study 11756577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9433634 — intervention group
Group type: EXPERIMENTAL
Intervention: Proband dependent (PD) sampling procedures
Number of subjects: 0
Study 9433634 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsingle ascertainment
Number of subjects: 0
Study 8345160 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 55
Study 8345160 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 55
Study 8345160 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam or Imipramine
Number of subjects: 55
Study 3104386 — intervention group
Group type: EXPERIMENTAL
Intervention: Free medical care (no cost-sharing)
Number of subjects: 5765
Study 3104386 — intervention group
Group type: COMPARATOR
Intervention: Cost-sharing insurance plans
Number of subjects: 5765
Study 30286704 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency electrical stimulation (LFES) during half-time recovery
Number of subjects: 22
Study 30286704 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 22
Study 30286704 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency electrical stimulation (LFES)
Number of subjects: 22
Study 29772839 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Schools: Skelmersdale (AS:Sk) intervention
Number of subjects: 0
Study 29772839 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal practice)
Number of subjects: 0
Study 27317093 — intervention group
Group type: EXPERIMENTAL
Intervention: febuxostat (10-60 mg/day)
Number of subjects: 500
Study 27317093 — intervention group
Group type: COMPARATOR
Intervention: non-pharmacological treatment
Number of subjects: 500
Study 25457732 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent school-based nutrition education intervention over 1 academic year
Number of subjects: 490
Study 25457732 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 490
Study 22147281 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour-change intervention
Number of subjects: 802
Study 22147281 — intervention group
Group type: COMPARATOR
Intervention: Control group (comparison area)
Number of subjects: 802
Study 20206354 — intervention group
Group type: EXPERIMENTAL
Intervention: 200mg of oral mifepristone followed 2 days later by 400 microg of sublingual misoprostol
Number of subjects: 199
Study 18823488 — intervention group
Group type: EXPERIMENTAL
Intervention: SurePath liquid-based cytology (LBC)
Number of subjects: 913
Study 18823488 — intervention group
Group type: COMPARATOR
Intervention: Conventional smear cytology
Number of subjects: 913
Study 17873260 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized decision aid (DA)
Number of subjects: 145
Study 17873260 — intervention group
Group type: EXPERIMENTAL
Intervention: DA + Coaching (DA + CC)
Number of subjects: 145
Study 17873260 — intervention group
Group type: COMPARATOR
Intervention: Control group (generic educational materials)
Number of subjects: 145
Study 17873260 — intervention group
Group type: EXPERIMENTAL
Intervention: DA
Number of subjects: 145
Study 17873260 — intervention group
Group type: EXPERIMENTAL
Intervention: DA + CC
Number of subjects: 145
Study 12483405 — intervention group
Group type: EXPERIMENTAL
Intervention: Technetium-99m ethyl cysteinate dimer SPET
Number of subjects: 140
Study 10952840 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (bolus of 5000 IU followed by an infusion of 1200 IU.h(‐1))
Number of subjects: 395
Study 10952840 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hirudin (0.2 mg.kg(‐1) bolus followed by 0.10 mg.kg(‐1).h(‐1))
Number of subjects: 395
Study 10952840 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose hirudin (0.4 mg.kg(‐1) bolus followed by 0.15 mg.kg(‐1).h(‐1))
Number of subjects: 395
Study 9062836 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-hour food deprivation (FD)
Number of subjects: 32
Study 9062836 — intervention group
Group type: COMPARATOR
Intervention: No food deprivation (NFD)
Number of subjects: 32
Study 9062836 — intervention group
Group type: EXPERIMENTAL
Intervention: High restrained eating (HR)
Number of subjects: 32
Study 9062836 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate restrained eating (MR)
Number of subjects: 32
Study 9062836 — intervention group
Group type: EXPERIMENTAL
Intervention: Low restrained eating (LR)
Number of subjects: 32
Study 8393055 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir prophylaxis (group 1)
Number of subjects: 42
Study 8393055 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir prophylaxis (group 2)
Number of subjects: 42
Study 8393055 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir prophylaxis and ganciclovir treatment (group 3)
Number of subjects: 42
Study 8393055 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis and treatment with ganciclovir (group 4)
Number of subjects: 42
Study 3088298 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy using carmofur (HCFU), mitomycin C (MMC) and immunopotentiators (group B)
Number of subjects: 166
Study 3088298 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C (MMC) and immunopotentiators (group A)
Number of subjects: 166
Study 30360679 — intervention group
Group type: EXPERIMENTAL
Intervention: semi‐immersive virtual reality training with BTS‐N
Number of subjects: 20
Study 30360679 — intervention group
Group type: COMPARATOR
Intervention: traditional cognitive training
Number of subjects: 20
Study 27450552 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg folate supplements
Number of subjects: 60
Study 24581069 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental nicotine vaccine
Number of subjects: 49
Study 24581069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 23574058 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction-based method
Number of subjects: 966
Study 23574058 — intervention group
Group type: COMPARATOR
Intervention: Opinion-based method
Number of subjects: 966
Study 21067660 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS), 200 micrograms, single dose
Number of subjects: 155
Study 21067660 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS), 200 micrograms, for 6 days
Number of subjects: 155
Study 21067660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 18976982 — intervention group
Group type: EXPERIMENTAL
Intervention: Active magnetic knee wrap (n=24)
Number of subjects: 50
Study 18976982 — intervention group
Group type: COMPARATOR
Intervention: Sham magnetic knee wrap (n=26)
Number of subjects: 50
Study 16769377 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin prophylaxis
Number of subjects: 999
Study 16769377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 999
Study 12806909 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening group
Number of subjects: 30
Study 12806909 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 12806909 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance group
Number of subjects: 30
Study 10674617 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF‐I/BP‐3 complex (1 to 4 mg/kg/day for 5 days)
Number of subjects: 22
Study 10674617 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 22
Study 8970458 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg dihydroergotamine mesylate
Number of subjects: 310
Study 8970458 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg dihydroergotamine mesylate
Number of subjects: 310
Study 8970458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study 1310110 — intervention group
Group type: EXPERIMENTAL
Intervention: High fiber, low fat diet
Number of subjects: 42
Study 1310110 — intervention group
Group type: COMPARATOR
Intervention: Low fiber, high fat diet
Number of subjects: 42
Study 6382172 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive strategy - sensory transformation
Number of subjects: 100
Study 6382172 — intervention group
Group type: COMPARATOR
Intervention: Other cognitive-behavioral pain-coping strategies
Number of subjects: 100
Study 30726533 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortataxel 75 mg/m2 i.v. every 3 weeks until disease progression
Number of subjects: 40
Study 28370614 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose concurrent chemoradiotherapy (CRT)
Number of subjects: 7219
Study 28370614 — intervention group
Group type: COMPARATOR
Intervention: Low-dose concurrent chemoradiotherapy (CRT)
Number of subjects: 7219
Study 26503069 — intervention group
Group type: EXPERIMENTAL
Intervention: GoFAR
Number of subjects: 30
Study 26503069 — intervention group
Group type: EXPERIMENTAL
Intervention: FACELAND
Number of subjects: 30
Study 26503069 — intervention group
Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 30
Study 22682958 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the hearing organ (n=58 tinnitus ears)
Number of subjects: 80
Study 22682958 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation together with cervical spine kinesitherapy (n=61 tinnitus ears)
Number of subjects: 80
Study 21496851 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-core biopsy
Number of subjects: 150
Study 21496851 — intervention group
Group type: COMPARATOR
Intervention: 12-core biopsy
Number of subjects: 150
Study 19121921 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulat (fermented food concentrate) taken twice daily for 4 weeks
Number of subjects: 48
Study 19121921 — intervention group
Group type: COMPARATOR
Intervention: Placebo (essence of vinegar)
Number of subjects: 48
Study 16822812 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent
Number of subjects: 20
Study 16822812 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stent
Number of subjects: 20
Study 14702153 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir plus stavudine and lamivudine
Number of subjects: 653
Study 14702153 — intervention group
Group type: COMPARATOR
Intervention: nelfinavir plus stavudine and lamivudine
Number of subjects: 653
Study 11373691 — intervention group
Group type: EXPERIMENTAL
Intervention: 192Ir
Number of subjects: 55
Study 11373691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 9259399 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) 20 mg/day
Number of subjects: 0
Study 9259399 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 182780 (ICI) 6 or 18 mg/day
Number of subjects: 0
Study 9259399 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment (NT) control group
Number of subjects: 0
Study 8503668 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuang Huang Lian herbs
Number of subjects: 96
Study 8503668 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuang Huang Lian herbs with antibiotics
Number of subjects: 96
Study 8503668 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics alone
Number of subjects: 96
Study 2966694 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 10
Study 2966694 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 10
Study 2966694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31092152 — intervention group
Group type: EXPERIMENTAL
Intervention: ticagrelor
Number of subjects: 13199
Study 31092152 — intervention group
Group type: COMPARATOR
Intervention: aspirin
Number of subjects: 13199
Study 28566194 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tVNS
Number of subjects: 13
Study 28566194 — intervention group
Group type: COMPARATOR
Intervention: Sham-T
Number of subjects: 13
Study 28566194 — intervention group
Group type: COMPARATOR
Intervention: tLS
Number of subjects: 13
Study 26202097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target systolic BP <140 mm Hg)
Number of subjects: 2794
Study 26202097 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based blood pressure management (target systolic BP <180 mm Hg)
Number of subjects: 2794
Study 23294485 — intervention group
Group type: EXPERIMENTAL
Intervention: IORT alone
Number of subjects: 230
Study 23294485 — intervention group
Group type: COMPARATOR
Intervention: IORT‐EBRT
Number of subjects: 230
Study 21480098 — intervention group
Group type: EXPERIMENTAL
Intervention: Tone-emitting otoscope
Number of subjects: 2251
Study 21480098 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing handicap questionnaire
Number of subjects: 2251
Study 21480098 — intervention group
Group type: EXPERIMENTAL
Intervention: Both screening strategies together
Number of subjects: 2251
Study 21480098 — intervention group
Group type: COMPARATOR
Intervention: No screening (control group)
Number of subjects: 2251
Study 19412676 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet with nuts
Number of subjects: 106
Study 19412676 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet with virgin olive oil (VOO)
Number of subjects: 106
Study 19412676 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 106
Study 16322886 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction video seen
Number of subjects: 100
Study 16322886 — intervention group
Group type: EXPERIMENTAL
Intervention: Palpation aid used
Number of subjects: 100
Study 16322886 — intervention group
Group type: COMPARATOR
Intervention: Instruction video not seen
Number of subjects: 100
Study 16322886 — intervention group
Group type: COMPARATOR
Intervention: Palpation aid not used
Number of subjects: 100
Study 15320644 — intervention group
Group type: EXPERIMENTAL
Intervention: Full range of motion training (Group 1: N = 11)
Number of subjects: 56
Study 15320644 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial range of motion training (Group 2: N = 15)
Number of subjects: 56
Study 15320644 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of partial and full range of motion training (Group 3: N = 30)
Number of subjects: 56
Study 15320644 — intervention group
Group type: COMPARATOR
Intervention: Partial range of motion training
Number of subjects: 56
Study 11918129 — intervention group
Group type: EXPERIMENTAL
Intervention: Loprinone hydrochloride (0.3 pg/kg/min)
Number of subjects: 30
Study 11918129 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 9631203 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal detection distractor
Number of subjects: 50
Study 9631203 — intervention group
Group type: EXPERIMENTAL
Intervention: Light detection distractor
Number of subjects: 50
Study 9631203 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral imagining distractor
Number of subjects: 50
Study 9631203 — intervention group
Group type: COMPARATOR
Intervention: No distraction
Number of subjects: 50
Study 9631203 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagining an enjoyable holiday
Number of subjects: 50
Study 7712736 — intervention group
Group type: EXPERIMENTAL
Intervention: Graft reactions in patients with reported symptoms (redness, sensitivity to light, loss of vision, pain)
Number of subjects: 456
Study 7712736 — intervention group
Group type: COMPARATOR
Intervention: Scheduled examinations in the first postoperative year
Number of subjects: 456
Study 7712736 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports of red eye and vision loss
Number of subjects: 456
Study 7712736 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of reaction
Number of subjects: 456
Study 7712736 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of patients
Number of subjects: 456
Study 2503295 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives containing 50 ug of ethinyl estradiol combined with 250 mg levonorgestrel
Number of subjects: 680
Study 2503295 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives containing 30 ug of ethinyl estradiol combined with 250 mg levonorgestrel
Number of subjects: 680
Study 2503295 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (50 ug and 30 ug ethinyl estradiol)
Number of subjects: 680
Study 797410 — intervention group
Group type: EXPERIMENTAL
Intervention: fenoterol (400 mug)
Number of subjects: 20
Study 797410 — intervention group
Group type: EXPERIMENTAL
Intervention: SCH 1000 (40 mug)
Number of subjects: 20
Study 797410 — intervention group
Group type: EXPERIMENTAL
Intervention: fenoterol (400 mug) and SCH 1000 (40 mug) combination
Number of subjects: 20
Study 31290017 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD)
Number of subjects: 40
Study 31290017 — intervention group
Group type: COMPARATOR
Intervention: Control (without EMD)
Number of subjects: 40
Study 30793687 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-led total sanitation program
Number of subjects: 1170
Study 27787464 — intervention group
Group type: COMPARATOR
Intervention: 2-second eccentric contractions
Number of subjects: 30
Study 27787464 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-second eccentric contractions
Number of subjects: 30
Study 27787464 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-second eccentric contractions
Number of subjects: 30
Study 26419668 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapaconazole tosylate 2% cream
Number of subjects: 60
Study 26419668 — intervention group
Group type: COMPARATOR
Intervention: Ketoconazole 2% cream
Number of subjects: 60
Study 23793133 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (4.5 g green tea/330 ml, providing approximately 400 mg catechins)
Number of subjects: 43
Study 23793133 — intervention group
Group type: COMPARATOR
Intervention: Water (330 ml)
Number of subjects: 43
Study 19117287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracapsular microdebridement
Number of subjects: 156
Study 19117287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracapsular coblation
Number of subjects: 156
Study 19117287 — intervention group
Group type: COMPARATOR
Intervention: Traditional extracapsular electrocautery
Number of subjects: 156
Study 19117287 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of all three techniques
Number of subjects: 156
Study 19117287 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider
Number of subjects: 156
Study 17483857 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Psychoeducation (GPE) - 4 sessions delivered during hospital admission
Number of subjects: 48
Study 17483857 — intervention group
Group type: COMPARATOR
Intervention: No sessions of GPE with usual care
Number of subjects: 48
Study 15451390 — intervention group
Group type: EXPERIMENTAL
Intervention: SGS742 (600 mg t.i.d. for 8 weeks)
Number of subjects: 110
Study 15451390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 11819837 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraluminal stent installation combined with intra-arterial drug infusion
Number of subjects: 281
Study 11819837 — intervention group
Group type: COMPARATOR
Intervention: Intraluminal stent installation only (control group)
Number of subjects: 281
Study 10084353 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumer advocacy program
Number of subjects: 0
Study 10084353 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumer advocates
Number of subjects: 0
Study 8030601 — intervention group
Group type: EXPERIMENTAL
Intervention: NaFeEDTA
Number of subjects: 10
Study 8030601 — intervention group
Group type: COMPARATOR
Intervention: FeSO4
Number of subjects: 10
Study 29580220 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused online guided self-help (GSH)
Number of subjects: 192
Study 29580220 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face trauma-focused cognitive behaviour therapy (TFCBT)
Number of subjects: 192
Study 26846860 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure-lowering treatment
Number of subjects: 2069
Study 25478237 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation over the left primary auditory cortex (verum group)
Number of subjects: 23
Study 25478237 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (sham group)
Number of subjects: 23
Study 25478237 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (n = 12)
Number of subjects: 23